Agenda
| |||
DAY ONE: TUESDAY, JULY 7, 2009 | |||
| 8:30 – 9:00 a.m. | Registration | ||
| 9:00 – 9:15 a.m. |
Welcome and Opening Remarks Nora Volkow, M.D. Director National Institute on Drug Abuse | ||
| 9:15 – 9:30 a.m. |
Regulatory Perspective Antonia Mattia, Ph.D. Food and Drug Administration | ||
| CAFFEINE’S REWARDING AND BEHAVIORAL EFFECTS: A PHARMACOLOGICAL PRIMER | |||
| 9:30 – 10:00 a.m. | Adenosine Receptor Heteromers as Targets for the Psychostimulant Effects of Caffeine | ||
|
Sergi Ferre, M.D., Ph.D. National Institute on Drug Abuse | |||
| 10:00 – 10:30 a.m. |
Adenosine and Dopamine Receptor Interactions in Striatum and Caffeine-Induced Behavioral Activation Vickram Ramkumar, Ph.D. Southern Illinois University School of Medicine | ||
| 10:30 – 11:00 a.m. |
Caffeine Effects on DA Transmission Gianluigi Tanda, Ph.D. National Institute on Drug Abuse | ||
CAFFEINE: EFFECTS ON COGNITIVE PERFORMANCE | |||
| 11:00 – 11:30 a.m. |
Caffeine Effects on Cognitive Performance, Mood and Energy Harris Lieberman, Ph.D. Army Research Institute of Environmental Medicine | ||
| 11:30- 12:00 p.m. |
Comparative Studies of Stimulant Action as Countermeasures for Higher Order Cognition and Executive Function Impairment that Results from Disrupted Sleep Patterns William Killgore, Ph.D. McLean Hospital, Harvard Medical School | ||
| 12:00 – 12:30 p.m. |
Caffeine and Cognitive Performance With and Without Sleep Deprivation David Dinges, PhD. University of Pennsylvania | ||
| 12:30 - 1:00 p.m. |
Comparing the Benefits of Caffeine, Naps and Placebo on Verbal, Motor and Perceptual Memory Sara Mednick, Ph.D. University of California, San Diego | ||
| 1:00 – 2:30 p.m. | Lunch - On Your Own | ||
CAFFEINE AND HUMAN DISEASE | |||
| 2:30 – 3:00 p.m. |
Coffee, Caffeine, and CVD Ahmed El-Sohemy, Ph.D. University of Toronto | ||
| 3:00 – 3:30 p.m. |
Coffee, Diabetes, and Weight Control James Greenberg, Ph.D. Brooklyn College of the City University of New York | ||
| 3:30 – 4:00 p.m. |
Adenosine A2A Receptor Antagonists and Parkinson’s Disease; State of the Art and Future Directions Nicola Simola University of Cagliari | ||
| 4:00 – 4:30 p.m. |
Caffeine, Sleep and Wakefulness: Implications of New Understanding About Withdrawal Reversal Jack James, Ph.D. National University of Ireland | ||
| 4:30 – 5:00 p.m. |
Discussion and Wrap-up Allison Hoffman, Ph.D. National Institute on Drug Abuse | ||
DAY TWO: WEDNESDAY, JULY 8, 2009 | |||
| HUMAN STUDIES: WHEN COULD CAFFEINE USE BECOME | |||
| 9:00 – 9:30 a.m. |
Does Caffeine Dependence Fit the “Classic” Definition of Drug Dependence and Caffeine Withdrawal? Roland Griffiths, Ph.D. Johns Hopkins University | ||
| 9:30 – 10:00 a.m. |
Caffeinated Cocktails: Energy Drink Consumption, High-Risk Drinking, and Alcohol-related Consequences Among College Students Mary Claire O’Brien, M.D. Wake Forest University | ||
| 10:00 – 10:30 a.m. |
Caffeine Dependence in Combination with a Family History of Alcoholism Predicts Continued Use of Caffeine During Pregnancy Dace Svikis, Ph.D. Virginia Commonwealth University | ||
| 10:30 – 11:00 a.m. |
Caffeine Intake, Toxicity and Dependence and Lifetime Risk for Psychiatric and Substance Use Disorders: An Epidemiologic and Co-twin Control Analysis Kenneth Kendler, M.D. Virginia Commonwealth University | ||
| 11:00 a.m. - 12:00 p.m. |
Group Discussion on Future Research Agenda | ||
| 12:00 p.m. | Adjourn | ||
Click here to download the agenda.
